Cash Flow Arrowhead Pharmaceuticals, Inc. Cash flow Statement
Figures in Million
Consolidated Cash Flow Results
Sep'25
Sep'24
Sep'23
Sep'22
Sep'21
Sep'20
No of Months
12
12
12
12
12
12
Profit Before Tax
51.00
-612.00
-206.00
-172.00
-140.00
-84.00
Adjustment
0.00
0.00
0.00
0.00
0.00
0.00
Changes In working Capital
-18.00
25.00
-51.00
-98.00
226.00
-60.00
Cash Flow after changes in Working Capital
0.00
0.00
0.00
0.00
0.00
0.00
Cash Flow from Operating Activities
179.00
-462.00
-153.00
-136.00
171.00
-95.00
Cash Flow from Investing Activities
-129.00
-420.00
-96.00
-5.00
-141.00
-240.00
Cash Flow from Financing Activities
74.00
870.00
253.00
65.00
11.00
257.00
Net Cash Inflow / Outflow
123.00
-8.00
3.00
-76.00
40.00
-78.00
Opening Cash & Cash Equivalents
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent of Subsidiaries under liquidations
0.00
0.00
0.00
0.00
0.00
0.00
Translation adjustment on reserves / op cash balances foreign subsidiaries
0.00
0.00
0.00
0.00
0.00
0.00
Effect of Foreign Exchange Fluctuations
0.00
4.00
0.00
0.00
0.00
0.00
Closing Cash & Cash Equivalent
0.00
0.00
0.00
0.00
0.00
0.00
Figures in USD Million
Seasonal companies are compared with the same quarter last year
Seasonal companies are compared with the same quarter last year
Compare Cash Flow Results of Arrowhead Pharmaceuticals, Inc.
Figures in Million
consolidated Cash Flow Results
Change(USD)
Change(%)
Profit Before Tax
51.533
-740.359000001189
791.00
106.96%
Adjustment
0
0
0.00
0.00%
Changes In working Capital
-18.235
-10.1040000000162
-8.00
-80.47%
Cash Flow after changes in Working Capital
0
0
0.00
0.00%
Cash Flow from Operating Activities
179.552
-570.570000000916
749.00
131.47%
Cash Flow from Investing Activities
-129.294
225.803000000363
-354.00
-157.26%
Cash Flow from Financing Activities
74.006
166.944000000268
-92.00
-55.67%
Net Cash Inflow / Outflow
123.863
-177.823000000286
300.00
169.66%
Opening Cash & Cash Equivalents
0
0
0.00
0.00%
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0
0
0.00
0.00%
Cash & Cash Equivalent of Subsidiaries under liquidations
0
0
0.00
0.00%
Translation adjustment on reserves / op cash balances foreign subsidiaries
0
0
0.00
0.00%
Effect of Foreign Exchange Fluctuations
-0.401
0
0.00
0.00%
Closing Cash & Cash Equivalent
0
0
0.00
0.00%
Cash Flow - Snapshot (Consolidated) - Sep'25
YoY Growth in year ended Sep 2025 is 138.79% vs -200.77% in Sep 2024
Sep'25
Sep'24
Change(%)
Cash Flow from Operating Activities
179.55
-462.85
138.79%
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
